<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>117(7)</volume><submitter>Gayarre J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Despite a high prevalence of deleterious missense variants, most studies of RAD51C ovarian cancer susceptibility gene only provide in silico pathogenicity predictions of missense changes. We identified a novel deleterious RAD51C missense variant (p.Arg312Trp) in a high-risk family, and propose a criteria to prioritise RAD51C missense changes qualifying for functional analysis.&lt;h4>Methods&lt;/h4>To evaluate pathogenicity of p.Arg312Trp variant we used sequence homology, loss of heterozygosity (LOH) and segregation analysis, and a comprehensive functional characterisation. To define a functional-analysis prioritisation criteria, we used outputs for the known functionally confirmed deleterious and benign RAD51C missense changes from nine pathogenicity prediction algorithms.&lt;h4</pubmed_abstract><journal>British journal of cancer</journal><pagination>1048-1062</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5625680</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.</pubmed_title><pmcid>PMC5625680</pmcid><pubmed_authors>Osorio A</pubmed_authors><pubmed_authors>Gayarre J</pubmed_authors><pubmed_authors>Garcia MJ</pubmed_authors><pubmed_authors>Urioste M</pubmed_authors><pubmed_authors>Palacios J</pubmed_authors><pubmed_authors>Benitez J</pubmed_authors><pubmed_authors>Martin-Gimeno P</pubmed_authors><pubmed_authors>Paumard B</pubmed_authors><pubmed_authors>Fernandez V</pubmed_authors><pubmed_authors>Rojo A</pubmed_authors><pubmed_authors>Barroso A</pubmed_authors><pubmed_authors>de la Hoya M</pubmed_authors><pubmed_authors>Caldes T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.</name><description>&lt;h4>Background&lt;/h4>Despite a high prevalence of deleterious missense variants, most studies of RAD51C ovarian cancer susceptibility gene only provide in silico pathogenicity predictions of missense changes. We identified a novel deleterious RAD51C missense variant (p.Arg312Trp) in a high-risk family, and propose a criteria to prioritise RAD51C missense changes qualifying for functional analysis.&lt;h4>Methods&lt;/h4>To evaluate pathogenicity of p.Arg312Trp variant we used sequence homology, loss of heterozygosity (LOH) and segregation analysis, and a comprehensive functional characterisation. To define a functional-analysis prioritisation criteria, we used outputs for the known functionally confirmed deleterious and benign RAD51C missense changes from nine pathogenicity prediction algorithms.&lt;h4</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Sep</publication><modification>2026-04-29T08:46:45.001Z</modification><creation>2019-03-26T23:57:03Z</creation></dates><accession>S-EPMC5625680</accession><cross_references><pubmed>28829762</pubmed><doi>10.1038/bjc.2017.286</doi></cross_references></HashMap>